| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-08 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-07 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |